[1] DAR A A,BHAT S A,GOGOI D,et al.Inhibition of notch signalling has ability to alter the proximal and distal TCR signalling events in human CD3+αβ T-cells[J].Molecular Immunology,2017,92:116-124.
[2] WANG X,GONG Z,LI S X,et al.Extranodal nasal-type natural killer/T-cell lymphoma with penile involvement:A case report and review of the literature[J].BMC Urology,2017,17(1):77.
[3] CLIFFORD T,WOOD M J,STOCKS P,et al.T-regulatory cells exhibit a biphasic response to prolonged endurance exercise in humans[J].European Journal of Applied Physiology,2017,117(8):1727-1737.
[4] FURLANETTO G,ALEGRETTI A P,FARIAS M G,et al.Cut-off value for absolute lymphocytes as an alternative for the immunophenotypic analysis of CD3+ T cells in the monitoring of immunosuppressive therapy with thymoglobulin[J].Journal Brasileiro de Nefrologia,2017,39(2):181-185.
[5] FUKAHORI H,CHIDA N,MAEDA M,et al.Effect of AS2521780,a novel PKC selective inhibitor,on T cell-mediated immunity[J].European Journal of Pharmacology,2014,745:217-222.
[6] JIN C,DUAN X,LIU Y,et al.T cell immunity induced by a bivalent Salmonella-based CEACAM6 and 4-1BBL vaccines in a rat colorectal cancer model[J].Oncology Letters,2017,13(5):3753-3759.
[7] 杨倩.黏膜免疫及其疫苗设计[M].北京:科学出版社,2016. YANG Q.Mucosal Immunization and Vaccine Strategies[M].Beijing:Science Press,2016.(in Chinese)
[8] ZHANG A,XU J,LAI H,et al.Age-related changes and distribution of T cell markers (CD3 and CD4) and Toll-like receptors(TLR2,TLR3,TLR4 and TLR7) in the duck lymphoid organs[J].Immunobiology, 2017,222(7):857-864.
[9] YANG J J,DAI L,YU Q H,et al.Histological and anatomical structure of the nasal cavity of Bama minipigs[J].PLoS One,2017,2(3):e0173902.
[10] LOH L,WANG Z,SANT S,et al.Human mucosal-associated invariant T cells contribute to antiviral influenza immunity via IL-18-dependent activation[J].Proceedings of the National Academy of Sciences of the United States of America,2016,113(36):10133-10138.
[11] GUO C,SHEN X,FU B,et al.CD3(bright) CD56(+) T cells associate with pegylated interferon-alpha treatment nonresponse in chronic hepatitis B patients[J].Scientific Reports,2016,6:25567.
[12] WOODLAND D L,RANDALL T D.Anatomical features of anti-viral immunity in the respiratory tract[J].Seminars in Immunology,2014,16(3):163-170.
[13] STENFELDT C,DIAZ-SAN SEGUNDO F,DE LOS SANTOS T,et al.The pathogenesis of foot-and-mouth disease in pigs[J]. Journal of Veterinary Science,2016,3:41.
[14] MCGILL J L,SACCO R E.T cells and the immune response to respiratory syncytial virus infection[J].Veterinary Immunology and Immunopathology,2016,181:24-29.
[15] MEYER SAUTEUR P M,DE GROOT R C A,ESTEV O S C,et al.The role of B cells in carriage and clearance of Mycoplasma pneumoniae from the respiratory tract of mice[J].Journal of Infectious Diseases,2017,217(2):298-309.
[16] HANOT MAMBRES D, MACHELART A,POTEMBERG G,et al.Identification of immune effectors essential to the control of primary and secondary intranasal infection with Brucella melitensis in mice[J].Journal of Immunology,2016,196(9):3780-3793.
[17] KYD J M,FOXWELL A R,CRIPPS A W.Mucosal immunity in the lung and upper respiratory[J].Vaccine,2001,19(17-19):2527-2533.
[18] GARG R,LATIMER L,GERDTS V,et al.Intranasal immunization with a single dose of the fusion protein formulated with a combination adjuvant induces long-term protective immunity against respiratory syncytial virus[J].Human Vaccines & Immunotherapeutics,2017,21:1-8.
[19] XIE Y,GAO P,LI Z.Recombinant adenovirus expressing P12A and 3C protein of the type O foot-and-mouth disease virus stimulates systemic and mucosal immune responses in mice[J].Biomed Research International,2016,2016:7849203.
[20] GARG R,THEAKER M,MARTINEZ E C,et al.A single intranasal immunization with a subunit vaccine formulation induces higher mucosal IgA production than live respiratory syncytial virus[J].Virology, 2016,499:288-297.
[21] PAWAR D,MANGAL S,GOSWAMI R,et al.Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery:Effect of mucoadhesive coating on antigen uptake and immune adjuvant activity[J].European Journal of Pharmaceutics and Biopharmaceutics,2013,85:550-559. |